Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • Photobucket

  • FDA Registered Contract Manufacturer

Mnemosyne Pharmaceuticals (Providence, RI) a development-stage small molecule company focused on neuropsychiatric disorders such as schizophrenia and Alzheimer’s, closed a $5.4M Series financing Participants include Access BridgeGap Ventures and Slater Technology Fund. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up.

Collegium Pharmaceutical (Cumberland, RI) a clinical-stage small molecule company focused on the development of innovative treatments for chronic pain, closed a $22.5M Series B financing. Participants include Longitude Capital, Skyline Ventures, Frazier Healthcare Ventures and Boston Millennia Partners.

NABsys (Providence, RI) a development stage dna sequencing company focused on nanopore arrays that can do not require amplification or labeling, closed a $10M Series C financing. Participants include Stata Venture. Thanx for your patience as we catch-up.

Beech Tree Labs (Providence, RI) a clinical-stage antiviral company focused on influenza and herpes, closed a $7M Series B financing. Participants were not identified.

NABsys (Providence, RI) a development-stage company focused on polymerase-free solid-state electronic detection DNA sequencing free of amplification or labeling focused point-of-care clinical use, closed a $7M Series B financing. Participants include Stata Venture Partners and Point Judith Capital. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well…this Friday!

  

to top of page...